This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB03244/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n4http://linked.opendata.cz/resource/drugbank/drug/DB03244/identifier/pubchem-compound/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03244/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03244/identifier/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03244
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB03244 n13:DB03244
dcterms:title
(S)-2-[4-(Aminomethyl)-1h-1,2,3-Triazol-1-Yl]-4-Methylpentanoic Acid
adms:identifier
n4:17754191 n7:46505093 n11:DB03244 n12:TA4
n5:IUPAC-Name
n6:271B5D22-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5D28-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5D27-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5D24-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5D25-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5D26-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5D20-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5D1E-363D-11E5-9242-09173F13E4C5 n6:271B5D21-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5D1F-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5D2E-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5D2F-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5D29-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5D2A-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5D2C-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5D2B-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5D2D-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5D34-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5D36-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5D37-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5D33-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5D32-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5D35-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5D23-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5D30-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5D31-363D-11E5-9242-09173F13E4C5